Cargando…

Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats

The study objective was to observe the treatment effect of the farnesoid X receptor (FXR) agonist GW4064 in a rat model of hilar cholangiocarcinoma to explore a new therapeutic target for gene therapy for hilar cholangiocarcinoma. Eighty male Wistar rats were randomly divided into four groups (treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jie-ping, Zhang, Meng-yu, Luo, Ming, Qin, Shu, Xia, Xian-ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640703/ https://www.ncbi.nlm.nih.gov/pubmed/36344586 http://dx.doi.org/10.1038/s41598-022-23539-5

Ejemplares similares

FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer
por: Lu, Lu, et al.
Publicado: (2023)

FXR expression in rats of hilar cholangiocarcinoma
por: Zhang, Meng-yu, et al.
Publicado: (2022)

NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance
por: Zhang, Meng-yu, et al.
Publicado: (2022)

Bsep expression in hilar cholangiocarcinoma of rat model
por: Zhang, Meng-yu, et al.
Publicado: (2021)

GW4064 Alters Gut Microbiota Composition and Counteracts Autism-Associated Behaviors in BTBR T+tf/J Mice
por: Liu, Jiayin, et al.
Publicado: (2022)

The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma
por: Di Matteo, S., et al.
Publicado: (2019)

Surgical treatment of hilar cholangiocarcinoma: retrospective analysis
por: Li, Bin, et al.
Publicado: (2023)

Resection of Hilar Cholangiocarcinoma
por: Strasberg, Steven M.
Publicado: (1998)

Non-surgical treatment of hilar cholangiocarcinoma
por: Inchingolo, Riccardo, et al.
Publicado: (2021)

Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring?
por: Li, Jian, et al.
Publicado: (2020)

Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stage III/IV hilar cholangiocarcinoma
por: Li, Qi-jiong, et al.
Publicado: (2019)

Laparoscopic resection of hilar cholangiocarcinoma
por: Lee, Woohyung, et al.
Publicado: (2015)

The value of caudate lobectomy in hilar cholangiocarcinoma treatment: A meta-analysis
por: Yang, Ming, et al.
Publicado: (2021)

Advances in diagnosis and treatment of hilar cholangiocarcinoma – a review
por: Zhimin, Geng, et al.
Publicado: (2013)

Neoadjuvant therapy in the treatment of hilar cholangiocarcinoma: Review of the literature
por: Frosio, Fabio, et al.
Publicado: (2019)

Endoscopic radiofrequency ablation for palliative treatment of hilar cholangiocarcinoma
por: Pereira, Pedro, et al.
Publicado: (2021)

Correction: Surgical treatment of hilar cholangiocarcinoma: retrospective analysis
Publicado: (2023)

The Role of Photodynamic Therapy for Hilar Cholangiocarcinoma
por: Cheon, Young Koog
Publicado: (2010)

PROTOCOL FOR LIVER TRANSPLANTATION IN HILAR CHOLANGIOCARCINOMA
por: ERNANI, Lucas, et al.
Publicado: (2021)

GW4064 attenuates lipopolysaccharide-induced hepatic inflammation and apoptosis through inhibition of the Toll-like receptor 4-mediated p38 mitogen-activated protein kinase signaling pathway in mice
por: Liu, Hsuan-Miao, et al.
Publicado: (2018)

Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma
por: Hu, Hai-Jie, et al.
Publicado: (2017)

Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals
por: Niu, Ho-Shan, et al.
Publicado: (2015)

Treatment of hilar cholangiocarcinoma of Bismuth-Corlette type III with hepaticojejunostomy
por: Lu, Bao-Chun, et al.
Publicado: (2013)

Changing Perspectives in the Assessment of Resectability of Hilar Cholangiocarcinoma
por: van Gulik, Thomas M., et al.
Publicado: (2007)

Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?
por: Ruys, Anthony T., et al.
Publicado: (2011)

Endoscopic drainage in patients with inoperable hilar cholangiocarcinoma
por: Park, Ye Jin, et al.
Publicado: (2013)

Prognostic significance of snail expression in hilar cholangiocarcinoma
por: Kong, Dalu, et al.
Publicado: (2012)

Prognostic significance of macrophage invasion in hilar cholangiocarcinoma
por: Atanasov, Georgi, et al.
Publicado: (2015)

Surgical management of hilar cholangiocarcinoma: Controversies and recommendations
por: Jena, Suvendu Sekhar, et al.
Publicado: (2023)

Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center’s experience
por: Li, Cheng-Gang, et al.
Publicado: (2020)

Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma
por: Yu, Zhimin, et al.
Publicado: (2017)

Hilar cholangiocarcinoma: Controversies on the extent of surgical resection aiming at cure
por: Xiang, Shuai, et al.
Publicado: (2014)

Bilateral versus unilateral radioactive stent insertion for hilar cholangiocarcinoma
por: Zhang, Yuchao, et al.
Publicado: (2022)

Stent insertion for inoperable hilar cholangiocarcinoma: Comparison of radioactive and normal stenting
por: Lin, Jia, et al.
Publicado: (2021)

Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma
por: Shi, Xiang-de, et al.
Publicado: (2016)

Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma
por: Jung, Pyung, et al.
Publicado: (2019)

Impact of bile acids on the growth of human cholangiocarcinoma via FXR
por: Dai, Jiaqi, et al.
Publicado: (2011)

The role of robotic surgery for the treatment of hilar cholangiocarcinoma: A systematic review
por: Brolese, Alberto, et al.
Publicado: (2022)

Preoperative ICG Test to Predict Posthepatectomy Liver Failure and Postoperative Outcomes in Hilar Cholangiocarcinoma
por: Li, Min, et al.
Publicado: (2021)

Tumor markers as a diagnostic key for hilar cholangiocarcinoma
por: Juntermanns, B, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7tovl9es7rqc5a0e73tt4oioc7